Clinical characterisation and molecular analysis of Wagner syndrome

British Journal of Ophthalmology

Volumn 91, Issue 5, 2007, Pages 655-659

  Meredith, Sarah P ^b   Richards, Allan J ^b   Flanagan, Declan W ^a   Scott, John D ^a   Poulson, Arabella V ^a   Snead, Martin P ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOCHONDROITIN SULFATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DNA DETERMINATION; FAMILY STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA DETACHMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STICKLER SYNDROME; VISUAL IMPAIRMENT; VITREORETINAL DEGENERATION; WAGNER DISEASE;

ADULT; CHILD; DIPLOPIA; DNA; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNDROME; UVEITIS, ANTERIOR; VISION DISORDERS;

EID: 34248231936     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.104406     Document Type: Article

References (20)

1. Billington BM, Leaver PK, McLeod D. Management of retinal detachment in the Wagner-Stickler syndrome. Trans Ophthalmol Soc UK 1985;104:875-9.
2. Zlotogora J, Sagi M, Schuper A, et al. Variability of Stickler syndrome. Am J Ophthalmol 1992;42:337-9.
3. Korkko J, Ritvaniemi P, Haataja L, et al. Mutation in type II procollagen (COL2A1) that substitutes aspartate for glycine alpha1-67 and that causes cataracts and retinal detachment: evidence for molecular heterogeneity in the Wagner syndrome and the Stickler syndrome (arthro-ophthalmopathy). Am J Hum Genet 1993;53:55-61.
4. Kloeckener-Gruissem B, Bartholdi D, Abdou M-T, et al. Identification of the genetic defect in the original Wagner syndrome family. Mol Vis 2006;12:350-5.
5. Wagner H. Ein bisher unbekanntes Erbleiden des Auges (Degeneratio hyaloideoretinalis hereditaria), beobachtet im Kanton Zurich. Klin Monatsbl Augenheilkd 1938;100:840-57.
6. Fryer AE, Upadhyaya M, Littler M, et al. Exclusion of COL2A1 as a candidate gene in a family with Wagner-Stickler syndrome. J Med Genet 1990;27:91-3.
7. Zech JC, Morle L, Vincent P, et al. Wagner vitreoretinal degeneration with genetic linkage refinement on chromosome 5q13-q14. Graefe's Arch Clin Exp Ophthalmol 1999;237:387-93.
8. Perveen R, Hart-Holden N, Dixon MJ, et al. Refined genetic and physical localization of the Wagner disease (WGN1) locus and the genes CRTL1 and CSPG2 to a 2- to 2.5-cM region of chromosome 5q14.3. Genomics 1999;57:219-26.
9. Graemiger RA, Niemeyer GG, Schneeberger SA, et al. Wagner vitreoretinal degeneration. Follow-up of the original pedigree. Ophthalmology 1995;102:1830-9.
10. Brown MB, Graemiger RA, Hergersberg M, et al. Genetic linkage of Wagner disease and erosive vitreoretinopathy to chromosome 5q13-14. Arch Ophthalmol 1995;113:671-5.
11. Miyamoto T, Inoue H, Sakamoto Y, et al. Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome. Invest Ophthalmol Vis Sci 2005;46:2726-35.
12. Mukhopadhyay A, Nikopoulos K, Maugeri A, et al. Erosive vitreoretinopathy and Wagner disease are caused by intronic mutations in CSPG2/versican that result in an imbalance of splice variants. IOVS 2006;47:3565-72.
13. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002;13:617-23.
14. Carter MS, Doskow J, Morris P, et al. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J Biol Chem 1995;270:28995-9003.
15. Gupta SK, Leonard BC, Damji KF, et al. A frame shift mutation in a tissue-specific alternatively spliced exon of collagen 2A1 in Wagner's vitreoretinal degeneration. Am J Ophthalmol 2002;133:203- 371.
16. Theocharis AD, Papageorgakopoulou N, Feretis E, et al. Occurrence and structural characterisation of versican-like proteoglycan in human vitreous. Biochimie 2002;84:1235-41.
17. LeBaron RG, Zimmermann DR, Ruoshlahti E. Hyaluronate binding properties of versican. J Biolog Chem 1992;267:10003-10.
18. Ladd AN, Cooper TA. Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol 2002;3:1-16.
19. Maumee IH, Stoll HU, Mets MB. The Wagner syndrome versus hereditary ophthalmopathy. Trans Am Ophthalmol Soc 1982;80:349-65.
20. Brown DM, Kimura AE, Weingeist TA, et al. Erosive vitreoretinopathy. A new clinical entity. Ophthalmology 1994;101:694-704.